Literature DB >> 2210604

Preoperative staging and risk analysis in esophageal carcinoma.

J R Siewert1, A H Hölscher, H J Dittler.   

Abstract

In esophageal cancer surgery a preoperative risk analysis of the patient and staging of the tumor are necessary to reduce postoperative mortality and to identify those patients who will benefit from primary surgery. A risk analysis includes the recording of cardiac, pulmonary, renal, hepatic and cerebral functions, and defines the functional limits of the various systems. Preoperatively it is most important to assess whether the primary tumor is completely resectable or not, because only patients undergoing complete tumor resection benefit from surgery with respect to the long-term prognosis. It is necessary to undertake a classification on the basis of tumor localization and local infiltration, which today can most reliably be evaluated by endoscopic ultrasonography. Advanced tumors above the bifurcation are associated with early infiltration of the tracheobronchial system, and should therefore receive preoperative treatment with combined radiotherapy and chemotherapy. Below the bifurcation, only T4-tumors invading neighboring structures should receive this pretreatment, whereas all others can be resected primarily.

Entities:  

Mesh:

Year:  1990        PMID: 2210604

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  The thoracic esophagus: sectional anatomy and radiosurgical applications.

Authors:  J M Chevallier; E Vitte; C Derosier; M Aupart; D Jeanbourquin; J J Sarcy; L Hannoun; R Parc
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

2.  [Multimodal therapy or surgery alone in adenocarcinoma of the esophagus?].

Authors:  M Stuschke; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

3.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

4.  Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?

Authors:  Y Tabira; T Okuma; K Kondo; M Yoshioka; T Mori; M Tanaka; K Nakano; N Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-08

Review 5.  Staging of squamous esophageal cancer: accuracy and value.

Authors:  A H Hölscher; H J Dittler; J R Siewert
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study.

Authors:  Shishir V Shah; Yogen Pavinchandra Chheda; Sundaram Kaliappan Pillai; Shakuntala Viren Shah
Journal:  Indian J Surg Oncol       Date:  2013-08-31

7.  Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus.

Authors:  M Baba; T Aikou; H Yoshinaka; S Natsugoe; T Fukumoto; H Shimazu; K Akazawa
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

8.  A prediction of hospital mortality after surgical treatment for esophageal cancer.

Authors:  G H Zhang; H Fujita; H Yamana; T Kakegawa
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.

Authors:  Hansheng Wu; Weitao Zhuang; Shujie Huang; Xueting Guan; Yuju Zheng; Zefeng Xie; Gang Chen; Jiming Tang; Haiyu Zhou; Liang Xie; Xiaosong Ben; Zihao Zhou; Zijun Li; Rixin Chen; Guibin Qiao
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.